
Archive
84 Posts


Trials 2022: Stem Cells, More Monoclonals, Diabetes Drugs, Anti-Virals and Devices

Cognitive studies, Research Administration
Aduhelm Vortex / Alzheimer Primer

$56K: Paying Aduhelm’s “rational…response” price…or spend it on a World Cruise?

Cognitive studies, Research Strategy
Looking for a Unified Theory…or is Alzheimer’s a Black Hole?

Molecular Amyloid Beta, Skeptics 2021 (or are they really Grinches?)

Painters & Dementia: Americans Peter Max, Chuck Close, William Utermohlen

Aduhelm: still controversial months after FDA’s “accelerated approval”

Clinical Trials, Research Strategy
Gene editing for amyloid (!?!?!?!?) Beyond aducanumab, but it’s not Alzheimer beta-amyloid
